Phospholipase A2 promotes the proliferation and growth of oesophageal adenocarcinoma through the activity of ERK1/2, and the use of ERK1/2 can inhibit the growth of oesophageal adenocarcinoma[19]. Here, MAPK3 is linked to esophageal adenocarcinoma.